143 related articles for article (PubMed ID: 8275460)
1. Concordance between karyotyping and in situ hybridization procedures in the detection of monosomy 9 in bladder cancer.
Smeets W; Schapers R; Hopman A; Pauwels R; Ramaekers F
Cancer Genet Cytogenet; 1993 Nov; 71(1):97-9. PubMed ID: 8275460
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma.
Eleuteri P; Grollino MG; Pomponi D; De Vita R
Eur J Cancer; 2001 Aug; 37(12):1496-503. PubMed ID: 11506956
[TBL] [Abstract][Full Text] [Related]
3. Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization.
Hopman AH; Moesker O; Smeets AW; Pauwels RP; Vooijs GP; Ramaekers FC
Cancer Res; 1991 Jan; 51(2):644-51. PubMed ID: 1985781
[TBL] [Abstract][Full Text] [Related]
4. A case of transitional cell carcinoma of the bladder with a del(9)(q11q21.2).
Bernués M; Casadevall C; Miró R; Caballín MR; Gelabert A; Egozcue J
Cancer Genet Cytogenet; 1993 Aug; 69(1):76-7. PubMed ID: 8374907
[TBL] [Abstract][Full Text] [Related]
5. DNA flow cytometric analysis and numerical chromosome 9 aberrations detected by interphase cytogenetics in superficial bladder TCC.
Eleuteri P; Grollino MG; Pomponi D; Calugi G; Rocchi M; De Vita R
Eur J Histochem; 1997; 41 Suppl 2():161-2. PubMed ID: 9859830
[No Abstract] [Full Text] [Related]
6. Nonrandom changes of chromosome 10 in bladder cancer. Detection by FISH to interphase nuclei.
Wang MR; Perissel B; Taillandier J; Kémény JL; Fonck Y; Lautier A; Benkhalifa M; Malet P
Cancer Genet Cytogenet; 1994 Mar; 73(1):8-10. PubMed ID: 8174080
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal aberrations in transitional cell carcinoma: its correlation with tumor behavior.
Yu DS; Chen HI; Chang SY
Urol Int; 2002; 69(2):129-35. PubMed ID: 12187044
[TBL] [Abstract][Full Text] [Related]
8. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
9. Structural chromosome 1 aberrations in transitional cell carcinoma of the bladder: interphase cytogenetics combining a centromeric, telomeric, and library DNA probe.
Poddighe PJ; Ramaekers FC; Smeets AW; Vooijs GP; Hopman AH
Cancer Res; 1992 Sep; 52(18):4929-34. PubMed ID: 1516049
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of numerical chromosomal aberrations in bladder cancer detected by fluorescence in situ hybridization].
Oka F
Nihon Ika Daigaku Zasshi; 1995 Oct; 62(5):501-10. PubMed ID: 7499466
[TBL] [Abstract][Full Text] [Related]
11. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis.
Fadl-Elmula I; Kytölä S; Pan Y; Lui WO; Derienzo G; Forsberg L; Mandahl N; Gorunova L; Bergerheim US; Heim S; Larsson C
Int J Cancer; 2001 Jun; 92(6):824-31. PubMed ID: 11351302
[TBL] [Abstract][Full Text] [Related]
12. Interphase cytogenetic studies of bladder cancer.
Wang MR; Perissel B; Taillandier J; Malet P
Bull Cancer; 1994 Dec; 81(12):1060-6. PubMed ID: 7742594
[TBL] [Abstract][Full Text] [Related]
13. Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer.
Matsuyama H; Bergerheim US; Nilsson I; Pan Y; Skoog L; Tribukait B; Ekman P
Cancer Genet Cytogenet; 1994 Oct; 77(2):118-24. PubMed ID: 7954321
[TBL] [Abstract][Full Text] [Related]
14. Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization.
Pycha A; Mian C; Posch B; Haitel A; El-Baz M; Ghoneim MA; Marberger M
J Urol; 1998 Sep; 160(3 Pt 1):737-40. PubMed ID: 9720535
[TBL] [Abstract][Full Text] [Related]
15. Detection of genetic aberrations in bladder cancer using in situ hybridization.
Ramaekers FC; Hopman AH
Ann N Y Acad Sci; 1993 Mar; 677():199-213. PubMed ID: 8098592
[No Abstract] [Full Text] [Related]
16. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
Shou J; Wang M; Ma J
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
[TBL] [Abstract][Full Text] [Related]
17. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers.
Hopman AH; van Hooren E; van de Kaa CA; Vooijs PG; Ramaekers FC
Mod Pathol; 1991 Jul; 4(4):503-13. PubMed ID: 1924281
[TBL] [Abstract][Full Text] [Related]
18. Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?
Bartlett JM; Watters AD; Ballantyne SA; Going JJ; Grigor KM; Cooke TG
Br J Cancer; 1998 Jun; 77(12):2193-8. PubMed ID: 9649132
[TBL] [Abstract][Full Text] [Related]
19. Genomic heterogeneity in bladder cancer as detected by fluorescence in situ hybridization.
Yokogi H; Wada Y; Moriyama-Gonda N; Igawa M; Ishibe T
Br J Urol; 1996 Nov; 78(5):699-703. PubMed ID: 8976763
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
